NASDAQ:NVLN - Novelion Therapeutics Price Target & Analyst Ratings

$0.88
-0.04 (-4.35 %)
(As of 06/25/2019 08:19 AM ET)
Today's Range
$0.82
Now: $0.88
$0.91
50-Day Range
$0.7530
MA: $0.97
$1.26
52-Week Range
$0.70
Now: $0.88
$4.10
Volume83,600 shs
Average Volume78,076 shs
Market Capitalization$16.76 million
P/E RatioN/A
Dividend YieldN/A
Beta2.34

Analyst Ratings

Novelion Therapeutics (NASDAQ:NVLN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Novelion Therapeutics in the last 12 months. Their average twelve-month price target is $5.00, suggesting that the stock has a possible upside of 468.18%. The high price target for NVLN is $5.00 and the low price target for NVLN is $5.00. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.00$5.00$5.00$5.00
Price Target Upside: 468.18% upside376.19% upside376.19% upside376.19% upside

Novelion Therapeutics (NASDAQ:NVLN) Consensus Price Target History

Price Target History for Novelion Therapeutics (NASDAQ:NVLN)

Novelion Therapeutics (NASDAQ:NVLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/14/2018Bloom BurtonDowngradeAccumulate ➝ HoldMediumView Rating Details
8/9/2018Royal Bank of CanadaLower Price TargetHold$6.00 ➝ $5.00MediumView Rating Details
(Data available from 6/25/2017 forward)
This page was last updated on 6/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel